Animal Health Companies | Market Research Future

Top Industry Leaders in the Animal Health Market

Animal Health Market *Disclaimer: List of key companies in no particular orderLatest Animal health Companies Update

August 2023: Boehringer Ingelheim expanded its portfolio of animal health products with the introduction of NexGard in India in August 2023. The expansion of the NexGard product line for tiny (weighing two to four kilograms) and medium (weighing four to ten kilograms) canines follows the successful launch of NexGard X and L earlier in 2020. NexGard is indicated for use in dogs and puppies as young as eight weeks and is administered monthly in highly palatable chewables that eliminate fleas, ticks, and mites before they can deposit eggs. The product is the only product approved by the FDA to prevent Lyme disease in canines by eliminating black-legged ticks. With the introduction of NexGard S and M, Boehringer Ingelheim intends to provide the same level of protection to small and medium-sized canines as to larger dogs.

October 2023: Athersys, Inc., a cell therapy and regenerative medicine company developed MultiStem for critical care indications and Multipotent Adult Progenitor Cell (MAPC) technology for equine, canine, and feline health applications, has signed a licensing agreement with Ardent Animal Health. Ardent is a privately held veterinary biotechnology company developing cancer treatments and regenerative medicine for animals. Ardent will pay an upfront fee to Athersys in exchange for an exclusive license to Athersys' Multipotent Adult Progenitor Cell (MAPC) technology for non-human mammal applications in the United States. The agreement comprises pre- and post-regulatory approval milestone payments for Athersys, including conditional and complete product approval payments for each species/indication combination. Athersys will also receive tiered royalties in the double-digit percentage range on commercial sales.

List of Animal health Key companies in the market